Unique Identifier:
ML-H030
Name on Requisition:
Lymphoid Multigene Panel
Product Line:
HEME
Panel Group:
NGS
Panel Name:
Multi-Gene NGS Panel >15 genes
Methodology
Molecular
NGS
Test Description and clinical significance
Genes
ATM, BTK, BIRC3, CARD11, CD79B, DDX3X, FBXW7, MAPK1, MYD88, NOTCH1, PIK3CA, PIK3CD, PTEN, PTPN6, SF3B1, TP53, XPO
Disease:
chronic lymphocytic leukemia (CLL), B- and T-cell lymphomas, and plasma cell neoplasms.
Lymphoid Multigene NGS Panel is a next-generation sequencing assay designed to detect clinically relevant mutations in genes recurrently altered in lymphoid malignancies, including chronic lymphocytic leukemia (CLL), B- and T-cell lymphomas, and plasma cell neoplasms. The panel identifies single nucleotide variants and small insertions/deletions across multiple genes, providing diagnostic, prognostic, and therapeutic information that supports risk stratification and selection of targeted therapies.
Specimen Requirements
Preparation:
PB, BM
Collection:
At least 0.5 ml EDTA, citrate (ACD) or Heparinized whole blood or bone marrow aspirates for DNA mutations
Stability:
96hours/4 to 7 days refrigerated
Unacceptable Conditions:
Specimen submitted is in the incorrect fixative or anticoagulant. Specimen received after the stability date. Gross hemolysis. Frozen specimen. Insufficient specimen. Unlabeled. Left un-refrigerated for an extended period.
Storage & Transport
Blood or bone marrow specimens should be kept at room temperature and preferably received within 96 hrs of drawing. Samples that are 4 to 7 days old should be refrigerated. Sufficient quantity of previously extracted DNA is acceptable if stored at appropriate temperature (short term at 2–8oC or long term at -15 to -25 oC) and should be transported on ice.
CPT(s)
81450
New York Approved
Yes
TAT
7
Requisition Type
Heme
Levels of Service
Full
DexS Code
NONE
Prefix
MI
*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.
With core values rooted in service and integrity, our leadership team sets the bar high.
We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.
siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).
We also hold select state licensure where required.